Thursday, March 28, 2019—The Food and Drug Administration (FDA) has cleared a novel cranial electrostimulation (CES) device (Cervella; Innovative Neurological Devices, Carmel, IN). Proprietary electro…
Thursday, March 21, 2019—The Food and Drug Administration (FDA) has approved solriamfetol (Sunosi; Jazz Pharmaceuticals, Dublin, Ireland) for the treatment of adults with excessive daytime sleepiness …
Logan Schneider, MD
March/April 2019—Sleep has a critical role in brain health and is an essential part of improving neurologic care for all of our patients.
Anne M. Morse, DO
March/April 2019—Sleep characterization in children may have a role in evaluation for risk of impaired development, behavior, mood, and self-regulation.
Raman K. Malhotra, MD
March/April 2019—Sleep problems are common and treatable in neurodegenerative disorders, and may also be a treatable risk factor and early biomarker.
Scott Kutscher, MD
March/April 2019—Elite athletes commonly have sleep disturbances and poor sleep quality made worse by the environmental demands of athletics.
Michael Howell, MD, FAAN, FAASM
March/April 2019—“If sleep doesn’t serve an absolutely vital function, it is the greatest mistake evolution ever made.”—Allan Rechschaffen, University of Chicago
Fiona Barwick, PhD
March/April 2019—Sleep disturbances are symptoms of psychiatric conditions that can worsen prognosis; however, nonpharmacologic treatments are available and effective.